BGI to hold 10th International Conference on Genomics in October

Jul 31 2015

The 10^th International Conference on Genomics (ICG-10, www.icg-10.org) will be held by BGI from October 22-25, 2015, in Shenzhen, China.

The conference is celebrating its 10^th anniversary this year. Since its inauguration in 2006, ICG has become one of the world's most influential annual meetings in the 'omics' fields, and is one of the most dynamic, enthusiastic, and enjoyable scientific gatherings.

ICG-10 focuses on recent breakthroughs and advances in 'omics' research that will further transform scientific discoveries into better health, treatments and cures in the next decade. It will include topics in clinical genomics, reproductive health, cancer, aging, precision medicine, metagenomics, synthetic genomics, as well as bioethics and the social implications. ICG-10 will bring together the most influential intellectual leaders and top scientists, as well as covering the hottest topics and the best practical applications.

Conference Highlights

• 20 Keynote Presentations
  featuring the most eminent scientists and thought leaders.
• 16 Sessions
  covering exciting topics in Omics sciences, and kicking off with a refreshing session on bioethics and education.
• 100 Speakers
  including Nobel laureates, academics, research luminaries and worldwide senior executives.
• Product Launch
  introducing the most advanced systems and products in the field, join the official launch of BGI's new system on-site.
• Exhibition
  showcasing more than 20 leading companies. Discover their latest offerings and solutions around Omics.
• Site Tour
  visit the largest genomics center in the world and explore the just completed China National Genebank.

Conference Topics

• Aging
• Agriculture
• Big data
• Bioethics and the social implications
• Cancer
• Clinical genomics
• Community genomes
• Immunotherapy
• Metagenomics
• Omics technology
• Plant genomics
• Precision medicine
• Rare disease
• Reproductive health
• Synthetic genomics

Featured Speakers

• Lieipng Chen, Director, Cancer Immunology Program at Yale Cancer Center, Yale University, USA
• Jenny Graves, Distinguished Professor, La Trobe University, Australia
• Leroy Hood, Co-founder, Institute for Systems Biology, USA
• Xin Lu, Founder, LICR Oxford at Ludwig Institute for Cancer Research, UK
• Elaine Lyon, Associate Professor of Clinical Pathology, University of Utah's School of Medicine, USA
• Richard Roberts, CSO at New England Biolabs, 1993 Nobel Laureate in Physiology or Medicine, USA
• Douglas C. Wallace, Director, Center for Mitochondrial and Epigenomic Medicine, Children's Hospital of Philadelphia Research Institute, USA